VOICE IN HEALTH

May 20 – 22  |  Boston, MA

Establishing Voice Tech for Patient Engagement, Vocal Biomarkers and Clinical Trials

Key Features of Voice in Health

Genuine Takeaways

Constructed alongside the pioneers of this industry, this summit is built around an end-to-end curated learning journey, with genuine outcomes set out from the start and reviewed at the finish. This will provide you with actionable takeaways to implement into your work.

10+

Hours of Networking

Take advantage of the senior-level networking opportunities available, without being stretched for time. Connect with industry leaders and exciting newcomers to advance your knowledge and work in voice in health.

Interactive Learning

Purposely designed to be as collaborative as possible: vocal biomarkers, patient engagement, and scalability will be explored in-depth through “hands-on” discussion-led sessions and open dialogue
(no “death-by-powerpoint” here!). 

“Voice first experiences have taken off across several industries in recent years. In healthcare, the uptake has been slower, but we’re now seeing key industry players embrace voice as an interface and promote the use of voice to improve patient experience and to promote better outcomes. The timing of this conference could not be better.”

James Wyman, Chief Operating Officer, Pillo Health 

Expert Speaker Faculty

Jim Harper

Co-Founder & Chief Operating Officer, Sonde Health

Rupal Patel

Chief Executive Officer, Vocal ID

Rupal Patel is founder and CEO of VocaliD, a voice AI company that creates custom digital voices. VocaliD is a pioneer in building personalized synthetic voices that leverage its crowdsourced Human Voicebank and breakthrough voice blending technology. VocaliD’s custom voices empower those living with speechlessness, enhance customer experiences, and bring things that talk to life. Rupal is currently on leave from Northeastern University where she is a tenured professor in the College of Computer and Information Science and the Department of Communication Sciences and Disorders. One of Fast Company’s 100 Most Creative people in Business, Rupal has been featured on TED, NPR, and in major international news and technology publications.

Cris De Luca

Global Head of Digital Innovation, Johnson & Johnson

Cris De Luca is currently the Global Director of Digital Innovation for Johnson & Johnson Innovation, based in Cambridge, Massachusetts. He's responsible for translating high-tech external innovation solutions across J&J’s Innovation Centers, JLABS incubators, and JJDC corp ventures supporting the Pharma, Consumer and Medical Device businesses. He formerly led Emerging Technology programs within research informatics at Novartis.

De Luca is most notably known for his role in the innovation economy since Co-Founding Ultra Light Startups, the oldest and largest startup-investor pitch accelerator in Boston and New York City with additional chapters in Silicon Valley and London. ULS accelerated 700+ bootstrapping startups with 26% having gone on to raise angel/venture funding, leading to several large-scale acquisitions by companies such as Apple, Trip Advisor and Singapore Telecom.

Cris is a Venture Fellow at FundRx and serves on the advisory boards of SXSW Health, AARP Health Innovation and VOICE Summit by Amazon Alexa. He holds a Masters in Computer Information Systems from Boston University and recognized as a 40 under 40 Healthcare Innovator by the Boston Business Journal and Medtech Boston.

Guillermo Cecchi

Principal Research Staff Member, IBM

Dr. Cecchi is a Principal Research Staff Member of IBM Research. Dr. Cecchi has been interested in diverse aspects of theoretical biology, including Brownian transport, molecular computation, spike reliability in neurons, song production and representation in songbirds, statistics of natural images and visual perception, statistics of natural language, and brain imaging.In recent years, he has developed a computational linguistics approach to quantify psychiatric conditions from short speech samples, applying it successfully to conditions as diverse as schizophrenia, mania, prodromal psychosis, and drug and alcohol intake, and directs the Computational Psychiatry and Neuroimaging research group in the Health Care and Life Sciences department of the T.J. Watson IBM Laboratory.

Jim Schwoebel

Chief Executive Officer, NeuroLex

Currently, Jim is the founding CEO of NeuroLex Labs, a company that is making voice computing accessible to everyone. He is also the author of Introduction to Voice Computing in Python, a textbook that outlines a new definition for voice computing with 200+ starter scripts on GitHub to train the next-generation of voice computing experts. Previously, Jim was a founding Partner of NeuroLaunch and CyberLaunch which invested in and grew over 22 companies in the neuroscience, cybersecurity, and machine learning verticals. He holds BS in biomedical engineering from Georgia Tech.

Claudio Hasler

Chief Executive Officer, Peak Profiling

Claudio Hasler is Co-Founder and CEO of PeakProfiling - a pioneer in speech sound analysis. Based on more than 20 years of research, the company is able to detect mental and physical disorders from the sound of the human voice. Previously, Mr. Hasler was leading the Business Intelligence and Analytics departments as well as all digital activities of an OTC player. Moreover, he has been working for Google in various roles, e.g. as Industry Manager.

Amar Kendale

Chief Product Officer, Livongo

Amar is passionate about developing products and technology that can shape the future of health and wellness, and improve lives. For over a decade, he has been responsible for bringing into focus the needs of stakeholders, patients, providers, manufacturers, and payers to drive the development and commercialization of a wide range of therapeutic and diagnostic products. At Livongo Health, Amar coordinates the company’s product management and design activities.

Prior to joining Livongo, Amar has held a variety of strategy, market development, product management, and marketing roles in high-growth companies. Most recently at MC10, he defined and validated opportunities for new stretchable, wearable electronics products and platforms, with diverse applications in consumer and healthcare markets ranging from sports impact indicators to neurological disease monitoring.

Earlier in his career, Amar developed medical devices and pharmaceutical products with high-powered teams that included serial innovators Bob Langer, George Whitesides, and Al Chin. His work has spanned bioabsorbable cardiovascular stents, cardiac surgery tools for intrathoracic visualization, hemostatic drug delivery foams, and implantable devices to treat obesity and diabetes.

Amar completed his Bachelor of Science and Master of Science in Mechanical Engineering from the Massachusetts Institute of Technology, and holds 8 patents.

Maura Rosenfeld

Chief Business Development Officer, Healthymize

Maura wakes up every morning excited to be part of Healthymize and the change being brought about by digital health. Maura joined the Healthymize team in 2017 and leads the business development. A veteran of technology companies, her previous experience in innovation and management includes serving as COO of MemTech, healthcare business development at Trendlines, and serving as General Counsel at RiT Technologies. She received her BA from the University of Michigan, JD from the University of Pittsburgh, and MBA from Manchester University.

James Wyman

Chief Operating Officer, Pillo Health

James is the co-founder & COO of Pillo Health – an in-home digital care management company. He is responsible for global finance & operations.

Prior to Pillo Health, James spent 7 years in the financial and technology industries. He began his career at Morgan Stanley, working for the firm in both London and New York. In 2011 he was part of the founding team of Morgan Stanley’s “Private Capital Markets” group, which specialized in raising equity and equity-linked capital for private companies in the technology, consumer retail, and healthcare services sectors.

James previously served as VP Partnerships and a board member of InSITE, a competitive fellowship program focused on strengthening the entrepreneurial ecosystem in New York City.

He completed his MBA at Columbia Business School, where he focused on Entrepreneurship & Venture Capital Investing, and has a Bachelor's Degree in Economics from Brown University. He is also a CFA Charter holder having passed all three exams on his first attempt.

Wolf Shlagman

Chief Executive Officer, Care Angel

Wolf Shlagman, a lifelong creative technologist, healthcare futurist and cognitive science evangelist, is currently CEO/Founder of Care Angel. As a serial entrepreneur, Wolf previously founded Consult a Doctor, which was acquired by Teladoc, INC (NYSE:TDOC), a Kleiner, Perkins portfolio company in 2013.

Wolf is an innovator that has been shaping and transforming the telehealth space since the earlier days of digital health, nearly 20 years ago. He is a technology and business leader with executive level strategic, technical and partnership development experience. He is recognized as beings a hands on leader who is driven by passion in the pursuit of building impactful, enterprise platforms and consumer solutions targeted to help alleviate the most pressing challenges affective the entire health ecosystem.

Wolf considers himself a professional tinkerer, an AI addict and a behavioral economics fanatic with a demonstrated history of success.

Maria Yancheva

Co-Founder and Chief Technology Officer, Winterlight Labs

Mainul Mondal

Founder & CEO, Ellipsis Health

Liam Kaufman

Chief Executive Officer, Winterlight Labs

Tal Wenderow,

Chief Executive Officer, Beyond Verbal

Tal Wenderow joined Beyond Verbal as President & CEO in Feb 2019. Tal is a seasoned
healthcare executive with ample experience in developing and commercializing innovative &
disruptive technologies.

Before joining the company, Tal co-founded Corindus Vascular Robotics `{`NYSE:CVRS`}` and in
his last position served as the Executive Vice President of International & Business
Development responsible for global sales and business partnerships of Corindus.

Tal holds a Bachelor of Science, Summa Cum Laude, in Mechanical Engineering from
Technion in Israel and completed Executive Program for Life Sciences at the Merage
Foundation, Merage Business School, University of California, Irvine, CA, having numerous
patents issued based on his inventions.

Oskar Kiwic

Chief Executive Officer & Lead Designer, CardioCube

Uma Vaidyanathan

Senior Scientific Program Manager, RDoC

Uma is a Senior Scientific Program Manager with the Research Domain Criteria (RDoC) initiative at the US National Institute of Mental Health. RDoC is a pioneering precision medicine approach to understanding biological and behavioral factors related to mental disorders. Uma’s work is centered around the question of how best to understand and classify mental disorders using various technologies. She has worked with various types of data including biometric, EEG, MRI and genetic, to answer these questions. She has 10 years of experience in academia and government, and has also worked as a Consultant Data Scientist at the World Bank and the Ashoka Foundation. Uma holds a PhD in Biological Psychology and a BA in Computer Science.

Taha Jangda

General Partner, HealthX Ventures

Tony Keating

Chief Executive Officer, ResApp Health

Tony Keating is the founding CEO of ResApp Health, a digital health company developing smartphone applications for the diagnosis and management of respiratory disease.

Prior to joining ResApp, Tony was Director, Commercial Engagement at UniQuest Pty Ltd, one of the global leaders in commercialisation of university technology. While at UniQuest, Tony held roles as interim CEO and Non-Executive Director for a number of privately-held, venture-capital funded start-up companies. Earlier in his career, Tony held business development and engineering management roles at Exa Corporation, makers of engineering simulation and visualization software.

Tony holds 3 engineering degrees (BEng, MEng and PhD), all from The University of Queensland. He also has an Executive Certificate of Management and Leadership from the MIT Sloan School of Management.

Joel Schwartz

Sr Manager, Quantitative Medicine & Clinical Tech Group, Biogen

Joel is an innovative and creative scientist who leverages experience in neurobiology, physics, instrumentation and statistics to generate and analyze large data sets. Currently, he is a Sr Manager at Biogen in the Quantitative Medicine and Clinical Technologies group. Joel started his career at Vanderbilt University where he obtained a PhD in the center for molecular neuroscience under Dr. Louis J DeFelice studying neurotransmitter transporter. After graduate school, Joel was hired as the managing director of imaging at the Stowers Institute for medical research. He was responsible for the development of light microscopy-based methodologies and image analysis. Joel left this position to purse work with Dr. Michael Ehlers at Duke University studying key molecular components for synaptic plasticity. He served as a technology lab lead within the Neuroscience Research Unit at Pfizer to build a strong technology base for advanced experimentation and informatics support. Joel served as a translator between the biologists, statisticians, physicists, and computer infrastructure professionals.

Throughout his career, Joel has done pioneering work in analytics and informatics to help provide a quantitative structure to extract meaningful data from imaging sources. He leveraged these skills in leadership positions in small biotechnology startup Biomedical Data Analytics. He has the skills and knowledge base to assemble multifaceted teams to develop and build novel technologies. CEO/Co-founder of Biomedical Data Analytics (BDA) focused on software-as-a-service (SaaS) for contract research. BDA provides advanced analytical tools on a proprietary cloud based platform to extract additional information from clinical and pre-clinical data. He has a unique perspective as a laboratory scientist, with extensive computational experience. The synergy of these efforts resulted in delivering novel AI methods to monitor videos of autistic patients to augment current clinical efforts for underserved rural populations.

In addition to his efforts at BDA, Joel is the lead instructor for Northeastern University’s Level Data Analytics program and Instructor in the Master of Professional Studies in Analytics programs. He teaches the analytics core sections, predictive analytics, programming, machine learning and big data for students pursuing a career in data science. These efforts have lead Joel to his current work at Biogen in the Quantitative Medicine and Clinical Technologies group. The QMCT group is devoted to using quantitative approaches to develop more robust outcomes in clinical trials with an overarching goal to provide higher success rates.

“Vocal biomarkers will fundamentally change diagnostics and monitoring for many diseases. The technology is evolving with rapid pace and the industry is expanding. The Voice in Health Summit is the first conference that brings all major players to the table – I am very much looking forward to it.”

Claudio Hasler, Chief Executive Officer, Peak Profiling

Conference Workshop

Monday, May 20th 2019

The Conference Workshop at Voice in Health has been specifically designed to answer the fundamental questions of voice tech in health.

As the next wave of digital innovation, the use of voice tech is beginning its implementation into the healthcare and pharma industries. With this field rapidly emerging, there is a need for those involved to understand the full cohort.

Led by the pioneers of the industry, this workshop will provide attendees the opportunity to develop their essential questions answered and be fully in the know, ready for the conference ahead.

Click to download full details of the conference workshop.

Workshop Leaders

Jim Harper, Co-Founder and COO, Sonde Health
Uma Vaidyanathan, Senior Scientific Program Manager, RDoC 
1:00  Presentation: What Role can Voice Play in Healthcare and Drug Development?
1:30  Breakout Discussions

Splitting into smaller working groups, each group will discuss their current views on voice in health as a concept and their views on the different facets of the industry.

  • Are we comfortable with the how the use of voice is being pursued in health?
  • Generally speaking, how do payers, pharma and regulatory authorities view the use of voice in digital health?
  • What lessons can we draw on from working with other related industries?
  • What remaining questions do we have about voice in health?
2:30  Refreshment Break
3:00  Feedback Discussions

Representative(s) from each group share the main points from their discussion to the whole group. Additional questions form moderators and other group members will be raised during this collaborative discussion.

4:00  End of Workshop

Leave this workshop with: 

  • Fundamental questions answered around how voice can aid healthcare and drug development
  • A deeper understanding of the current payer and provider perspectives on the use of voice in health and how these are looking to be advanced
  • Up-to-date information on the different ways pharma are involved in the industry
  • A fundamental understanding of the current privacy and security challenges
  • A stronger appreciation of the crucial questions facing the industry that will be tackled during the rest of the Summit.

Summit Agenda

Click to download our full event agenda.

8:00  Registration, Breakfast & Networking
Voice in Health – Demonstrating the Value of Voice
9:00   Chair’s Opening Presentation – a Brief History and Future Direction

Jim Harper, Co-Founder and COO, Sonde Health

9:25   Presentation – Using Voice and Audio for Disease Diagnosis, Management and Scalability within Healthcare

Tony Keating, Chief Executive Officer, ResApp Health

9:50  Interactive Panel and Open Q&A – How do we Demonstrate the Value and Evidence of Voice Tech in Health?

Tal Wenderow, Chief Executive Officer, Beyond Verbal
James Wyman, Chief Operating Officer, Pillo Health
Liam Kaufman, Chief Executive Officer, Winterlight Labs

10:30  Morning Refreshments & Networking
Patient Engagement Through Voice
11:00  Presentation – How can Voice be used to Improve Disease Management for Patients?

Oskar Kiwic, CEO & Lead Designer, CardioCube

11:25  Presentation – How can Voice be used to Aid Patient Engagement in the Home?

Amar Kendale, Chief Product Officer, Livongo

11:50  Interactive Panel and Open Q&A – How can we Improve Patient Engagement Through the use of Voice Tech?

Amar Kendale, Chief Product Officer, Livongo
Wolf Shlagman, Chief Executive Officer, Care Angel
Oskar Kiwic, CEO & Lead Designer, CardioCube
Tony Keating, Chief Executive Officer, ResApp

12:30  Long-Table Lunch & Networking
2:00                                Vocal Points: The Crucial Questions facing Voice Tech

 

Break off into smaller teams, hang your corporate hat at the door and work together to solve some of the industries most pressing issues. You will have the opportunity to work alongside the industry leaders to construct the fundamentals of the industry and advance your own understanding.

Topics to include:

Data samples – A limiting factor in this field is the lack of usable data sets that can be tested in a clinical setting. How can this be overcome to help further this industry?

Jim Harper, Co-Founder & COO, Sonde Health

Reimbursement – How can this technology produce a revenue stream and how can payers be informed that this tech has a positive ROI?

Maura Rosenfeld, Chief Business Development Officer, Healthymize

Security and Privacy – Voice technology is becoming a staple in the home as a lifestyle tool, but many are concerned when discussing private and sensitive data using this interface. How can users be educated to mitigate this and invite this technology into their homes?
3:30   Afternoon Refreshments & Networking
Vocal Biomarkers in Clinical Trials
4:10  Presentation – A look at Vocal Biomarkers Currently in Clinical Trials

Claudio Hasler, Chief Executive Officer, Peak Profiling

4:35  Presentation – Using Vocal Biomarkers as a Measure in Clinical Trials

Tal Wenderow, Chief Executive Officer, Beyond Verbal

5:00  Interactive Panel and Open Q&A – How do we Implement and Scale Vocal Biomarkers in Clinical Trials?

Jim Schwoebel, Chief Executive Officer, Neurolex
Claudio Hasler, Chief Executive Officer, Peak Profiling
Joel Schwartz, Quantitative Medicine & Clinical Tech Group, Biogen
Guillermo Cecchi, Principal Research Staff Member, IBM

5:40  Close of Day 1
Download Agenda to access full details of the event…
8:00  Breakfast & Networking
9:00  Chair’s Opening Remarks

Jim Schwoebel, Chief Executive Officer, Neurolex

Voice: Patients, Privacy & Security 
9:10   Hackathon Feedback Session

Obtain the consolidated feedback from Day 1’s Hackathon sessions. Each of the hosts will provide the summarised notes from each of the sessions so that attendees have actionable insights to implement after the event.

Jim Harper, Co-Founder & COO, Sonde Health
Maura Rosenfeld, Chief Business Development Officer, Healthymize

9:40  Interactive Panel and Open Q&A – How can we Overcome the Security, Privacy and Ethical Challenges facing Voice?

Rupal Patel, Chief Executive Officer, Vocal ID
Cris De Luca, Global Head of Digital Innovation, Johnson & Johnson
Adam Landman, Chief Information Officer, Brigham and Women’s Hospital
Maria Yancheva, Co-Founder and Chief Technology Officer, Winterlight Labs

10:20  Morning Refreshments & Networking
Patients, Implementation, Collaboration and Scaling Voice in Health
11:00  Presentation – How can Voice Technology be used in Optimizing Clinical Trials?

Joel Schwartz, Quantitative Medicine & Clinical Tech Group, Biogen

11:30  Presentation – Development and Implementation of Voice Technology in a Healthcare Environment

Mainul Mondal, Chief Executive Officer, Ellipsis Health

12:00  Long-Table Lunch & Networking
1:15   Interactive Panel and Open Q&A – Scaling Voice in Health for Robust Longevity and Summit Takeaways

Maura Rosenfeld, Chief Business Development Officer, Healthymize
Mainul Mondal, Chief Executive Officer, Ellipsis Health
Taha Jangda, General Partner, HealthX Ventures

1:55  Chair’s Summary

Jim Schwoebel, Chief Executive Officer, Neurolex

2:05   Close of Voice in Health 2019
Download Agenda to access full details of the event…
“The Voice in Health Summit presents a rare opportunity to bring together industry players at the forefront of bringing voice into healthcare. I am excited to have this opportunity to engage with leaders in the voice community and plot the path that can take us all forward.”

Maura Rosenfeld, Chief Business Development Officer, Healthymize

Venue

The Colonnade, Boston

We strive to provide inspirational venues that can provide the space needed for an open and widely networked event.

The 2019 summit is being held in the Colonnade, Boston,  a contemporary luxury hotel in Back Bay.

This elegant venue is the perfect place for learning, networking and relaxing.  Nestled in one of Boston’s most desirable neighborhoods, The Colonnade offers unmatched access to area attractions, shopping, dining, and the arts.

Guest rooms can be booked directly with the hotel.  We anticipate high demand and recommend that you book early to secure the best possible rate.

The Colonnade does not offer an exclusive rate for Voice in Health attendees.  We have included, in the welcome pack, details of alternative hotels close to the venue.

Registration

Sponsorship

Like you, our business goal is to deliver an exceptional and commercially viable service for our customers.   We are proud of our track record of producing world-class summits that attract a relevant and senior audience.

Key to our success is curating the right audience.  One where peers can network with speakers who are experts in their field.

Our attendees tell us that one of the main reasons they attend our summits is to advance partnership discussions and forge new business relationships.  To facilitate this (and help us to fund the event) we have a limited number of sponsor/supporter and partnership opportunities.

With the process of connecting with senior decision makers ever more challenging, our summits provide the opportunity to showcase your business and have those essential face to face conversations.

Contact Us

To ensure that the optimum audience mix is maintained we strictly limit the number of sponsors. This means that our sponsors can be confident they can have the meaningful conversations they seek – and our attendees know that the composition of the audience is just right.

We invite you to get in touch for a no-obligation conversation.  We will share our audience data with you and help you determine whether this summit is the right fit for you.

Contact Sam Confino on +44 203 865 9002 or
e-mail sam@greygreenmedia.com

Register For The Event

For pricing and booking options please click the button to go to the registration page.